HOME > ARCHIVE
ARCHIVE
- SEMINAR
July 10, 2006
- Generic Marketing Companies Asked to Cooperate in Follow-up Market Price Surveys
July 10, 2006
- Bayer to Sell Diagnostics Business to Siemens
July 10, 2006
- TOPIC an article
July 10, 2006
- MEDICAL DEVICES/DIAGNOSTICS NEWS IN BRIEF
July 10, 2006
- METI Proposes "Economic Growth Strategy Framework"
July 10, 2006
- NEW PRODUCTS
July 10, 2006
- Council Proposes Cuts of \11.4-14.3 Tril. Over Next 5 Years
July 10, 2006
- SEMINAR
July 10, 2006
- Otsuka's Mozavaptan Recommended for Approval
July 10, 2006
- Asahi Kasei Licenses Fasudil to CoTherix
July 10, 2006
- Proposed Vision Calls For Support of Vaccine Development
July 10, 2006
- SURVEY 2 articles
July 10, 2006
- HPB Sets Up Another Study Group to Promote Clinical Trials
July 10, 2006
- SURVEY 3 articles
July 3, 2006
- Generic Makers Concerned about Extension of Data Protection Period: IGPA Conference
July 3, 2006
- Epadel, Atelec Continue to Drive Mochida's Business
July 3, 2006
- 66th Annual Scientific Sessions of the American Diabetes Association
July 3, 2006
- Blopress Retained Rank as Top-selling Drug in FY2005
July 3, 2006
- Pediatric Clinical Trial of Ketek Temporarily Discontinued in US: sanofi-aventis
July 3, 2006
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
